Доказательная база эффективности пробиотиков

Эффективность пробиотиков
  • И. Ю. Мельникова, В. П. Новикова, Н. Б. Думова. Запоры у детей. — ГЭОТАР-Медиа. — М., 2009. — С. 69. — 144 с.

  • Андреев, Игорь Леонидович Человек и бактериальный мир: проблемы взаимодействия // Вестник РАН. — 2009. — № 1. — С. 41—49.

  • Хашке Ф., Ванг В., Пинг Г. и др. Клинические доказательства безопасности и эффективности пробиотического штамма бифидобактерий Bb12 в составе последующих молочных смесей и молока для детей раннего возраста. Вопр. дет. диетологии. 2004.

  • Воробьев А.А., Гершанович М.Л., Петров Л.Н. Пробиотики в комплексной терапии онкологических больных. М., 1998.

  • Корниенко Е.А., Дроздова С.Н., Серебряная Н.Б. Пробиотики как способ повышения эффективности эрадикации Helicobacter pylori у детей. Фарматека. 2005.

  • Горелов А.В., Усенко Д.В., Елезова Л.И. и др. Использование пробиотических продуктов в лечении кишечных инфекций у детей. Вопр. совр. пед. 2005.

  • Naidu FS, Bidlack WR, Clemens RA. Probiotic spectra of lactic acid bacteria. Ed. Clydesdale F.V. In: Critical Reviews in Food Science and Nutrition. Boca Raton (FL): CRC Press LLC, 1999.

  • Flamm G, Gold BD, Hoover DG et al. The General recognition of safety of Bifidobacteria, Lactobacilli and Streptococcus thermophilus for use in infant formula. Expert Panel Findings, Draft Report.

  • Shanahan F. Immunology. Therapeutic manipulation of gut flora. Science. 2000.

  • Fang H, Elina T et al. Modulation of humoral immune response through probioric intake. FEMS Immunol. Med. Microbiol. 2000.

  • Yan F, Polk DB. Probiotic bacterium prevenrs cytokineinduced apoptosis in intestinal epithelial cells. J. Biol. Chem. 2002.

  • Fedorak RN, Madsen KL. Probiotics and prebiotics in gastrointestinal disorders. Curr. Opin. Gastroenterol. 2004.

  • Rastall RA. Bacteria in the gut: friends and foes and how to alter the balance. J. Nutr. 2004.

  • Felley C. Michetti Probiotics and Helicobacter pylori. Best Pract. Res. Clin. Gastroenterol. 2003.

  • Hamilton-Miller JM. The role of probiotics in the treatment and prevention of Helicobacter pylori infection. Int. J. Antimicrob. Agents. 2003.

  • Burns AJ, Rowland IR. Antigenotoxicity of probiotics and prebiotics on faecal water-induced DNA damage in human colon adenocarcinoma cells. Mutat. Res. 2004.

  • Kalliomaki M, Salminen S, Arvilommi H et al. Probiotics in primary prevention of atopic disease: a randomised placebocontrolled trial. Lancet. 2001.

  • Kalliomaki M, Isolauri EJ. Probiotics during pregnancy and breastfeeding might confer immunomodulatory protection against atopic disease in the infant. Allergy Clin. Immunol. 2002.

  • Isolauri E, Arvola T, Sutas Y et al. Probiotics in the management of atopic eczema. Clin. Exp. Allergy. 2000.

  • Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J. Allergy Clin. Immunol. 1997.

  • Pessi T, Sutas Y, Hurme M, Isolauri E. Interleukin 10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin. Exp. Allergy. 2000.

  • Jones CA, Holloway JA, Popplewell EJ et al. Reduced soluble CD14 levels in amniotic fluid and breast milk are associated with the subsequent development of atopy, eczema, or both. J. Allergy Clin. Immunol. 2002.

  • Bin-Nun A, Bromiker R, Wilschanski M et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J. Pediatr. 2005.

  • Hoyos AB. Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int. J. Infect. Dis. 1999.

  • Dani C, Biadaioli R, Bertini G et al. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants: a prospective doubleblind study. Biol. Neonate. 2002.

  • Schanler RJ. The use of human milk for premature infants. Pediatr. Clin. North Am. 2001.

  • Lucas A, Cole TJ. Breast milk and neonatal necrotising enterocolitis. Lancet. 1990.